Cem Akin MD, PhD
Professor of Internal Medicine
[email protected]

Available to mentor
Cem Akin MD, PhD
Clinical Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Precision Health Initiative
    Recent Publications See All Publications
    • Journal Article
      Dilemma of Mast Cell Activation Syndrome: Overdiagnosed or Underdiagnosed?
      Akin C. J Allergy Clin Immunol Pract, 2024 Mar; 12 (3): 762 - 763. DOI:10.1016/j.jaip.2024.01.013
      PMID: 38458701
    • Journal Article
      Anaphylaxis: A 2023 practice parameter update.
      Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Abrams EM, Bernstein JA, Chu DK, Horner CC, Rank MA, Stukus DR, Collaborators , Burrows AG, Cruickshank H, Workgroup Contributors , Golden DBK, Wang J, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Waserman S, Joint Task Force on Practice Parameters Reviewers , Abrams EM, Bernstein JA, Chu DK, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Rank MA, Shaker MS, Stukus DR, Wang J. Ann Allergy Asthma Immunol, 2024 Feb; 132 (2): 124 - 176. DOI:10.1016/j.anai.2023.09.015
      PMID: 38108678
    • Journal Article
      Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study
      Giannetti M, Akin C, Livideanu CB, Sabato V, Van Daele P, Pongdee T, Barete S, Vadas P, Maurer M, Siebenhaar F, Triggiani M, Bonadonna P, Hartmann K, Guilarte M, Ogbogu , Gaudy C, Bidollari I, Green T, Lin H-M, Roche M, Sullivan E, Castells M, Elberink HO. Journal of Allergy and Clinical Immunology, 2024 Feb; 153 (2): ab254 DOI:10.1016/j.jaci.2023.11.811
    • Journal Article
      Initial Results from Summit: An On-going, 3-Part, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of Bezuclastinib in Adult Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
      Modena B, Rein LAM, Oh S, DeAngelo D, Hunter A, Akin C, Castells M, Manning M, Herrscher R, Ustun C, Kirshenbaum A, Livideanu CB, Boggs N, Yi CA, Siebenhaar F, George T, Exter B, Zhang J, Pilla A, Jolin H, Easton R, Bose P. Journal of Allergy and Clinical Immunology, 2024 Feb; 153 (2): ab224 DOI:10.1016/j.jaci.2023.11.722
    • Journal Article
      Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
      Valent P, Akin C, Arock M. Curr Allergy Asthma Rep, 2024 Mar; 24 (3): 133 - 141. DOI:10.1007/s11882-024-01124-2
      PMID: 38308674
    • Journal Article
      Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF©) and determination of a threshold score for moderate symptoms.
      Shields AL, Taylor F, Lamoureux RE, Padilla B, Severson K, Green T, Boral AL, Akin C, Siebenhaar F, Mar B. Orphanet J Rare Dis, 2023 Mar 25; 18 (1): 69 DOI:10.1186/s13023-023-02661-1
      PMID: 36964624
    • Journal Article
      Mastocytosis: Aiming for the Right Targets.
      Akin C. Immunol Allergy Clin North Am, 2023 Nov; 43 (4): xv - xvi. DOI:10.1016/j.iac.2023.06.001
      PMID: 37758415
    • Journal Article
      Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis.
      Akin C. Immunol Allergy Clin North Am, 2023 Nov; 43 (4): 743 - 750. DOI:10.1016/j.iac.2023.05.001
      PMID: 37758410